Overview


According to FutureWise analysis, the high-throughput process development market in 2025 is US$12.41 billion, and is expected to reach US$26.92 billion by 2033 at a CAGR of 10.16%.

High throughput screening is when automated equipment is used to quickly test thousands to millions upon samples for biological activity. This can be done at the model organism, cellular or pathway level, as well as at the molecular level. High-throughput systems are a well-established method for drug discovery. There are hundreds of thousands potential drug candidates that must be screened. Miniaturization is one of the key mechanisms to increasing throughput. Because smaller experimental platforms and reagent volumes are required, more experiments can be performed with fewer resources. This reduces costs. Microfluidics allows for fluid manipulation at the submillimetre level. When working with precious materials, it is beneficial to use smaller sample and reagent volume. Additionally, microfluidics makes it possible to leverage microscale fluid phenomena. This allows researchers far more control over the spatiotemporal dynamics of the experiment. Robotics, liquid-handling robotics, and automation are all technologies that allow for high throughput. Drugs that target the central nerve system (CNS), are notoriously prone to failure. For clinical trials of neurodegenerative conditions such as Alzheimer's, this failure rate can reach >99%. Preclinical testing of these medications is still heavily dependent on in vitro screen, which is costly, time-consuming, and expensive. In vitro model systems that mimic the blood-brain barrier have been developed to evaluate drug delivery to brain. There has been much attention on this topic. These cell culture systems are able to reduce the time and costs of drug screening as well as address ethical concerns regarding animal testing. High-throughput technologies have made it possible for these assays meet the current demands of pharmacological developments. High-throughput sequences have greatly helped in rapid whole-genome sequencing of infectious diseases, such as the COVID-19 pandemic, and tracking antimicrobial resistant.11-12 However, upstream techniques for preparing samples for sequencing remain a challenge.

With the rise of biopharmaceutical, the global market in high throughput process development will continue to grow. Throughput process design aims to decrease the time required to manufacture a product and increase its performance. In high throughput computing, multiple servers are deployed over a long time to complete a computational task. This is a major factor driving the global market growth for high-throughput process design. This market is being significantly boosted by the availability of high throughput tools that can be used to simultaneously test media and chromatography concerns. High-throughput screening allows researchers to perform millions upon millions of chemical, biological, and pharmacological testing during drug discovery. The field of drug discovery has gained some momentum and the market is projected to grow over the forecast period. Market growth is limited by factors such the large cost of technologies and infrastructure, as well the lack of adequate infrastructure facilities. The Global High Throughput Process Development Market will experience a slowdown in its growth during the forecast period due to difficulties in incorporating existing industry models. Throughput has attracted many customers due to its technological advancements. There are many technologies and instruments that can be used to aid businesses in developing early manufacturing processes within a short timeframe while also collecting sufficient data to support these processes. These high-throughput efforts in process development are driving the market forward.

FutureWise Market Research has instantiated a report that provides an intricate analysis of High Throughput Process Development Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the High Throughput Process Development Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Danaher
  • GE Healthcare
  • Agilent technologies
  • Merck Millipore
  • Thermo Fisher Scientific
  • Sartorius Stedim Biotech SA
  • Bio-Rad Laboratories Inc.
  • PerkinElmer Inc.
  • Eppendorf SE
  • Tecan Group AG
  • Repligen Corporation
  • Pall Corporation
  • Shimadzu Corporation
  • Hamilton Company
  • KBI Biopharma
  • WuXi AppTec
  • BioCentriq
  • Premas Biotech

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product & Services

  •  Consumables
    • Miniature Prepacked Columns
    • Micro-well Filter Plates
    • Miniature Disposable Bioreactor
    • Micropipettes and Pipette Tips
    • Other Consumables
  • Instruments
    • Automatic Integrated Workstation
    • Automated Miniature Bioreactor System
  • Services
  • Software

By End-user

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Academic Research Institutes

By Technology

  • Chromatography
    •  Affinity Chromatography
    •  Io-exchange
    •  Multi-modal chromatography
    •  Other Chromatography Technologies
  • Ultraviolet-visible Spectroscopy
  • Other Technologies

By Molecule Type

  •  Monoclonal Antibodies
  •  Recombinant Pro-insulin
  •  Polysaccharide vaccines
  •  Other Molecule types

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  •  To provide with an exhaustive analysis on the High Throughput Process Development Market By Product & Services, By End-user, By Technology, By Molecule Type and By Region.
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  •  To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   High Throughput Process Development Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of High Throughput Process Development Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   High Throughput Process Development Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   High Throughput Process Development Market, By Product & Services Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Consumables
         1.1. Miniature Prepacked Columns
         1.2. Micro-well Filter Plates
         1.3. Miniature Disposable Bioreactor
         1.4. Micropipettes and Pipette Tips
         1.5. Other Consumables
        2. Instruments
         2.1. Automatic Integrated Workstation
         2.2. Automated Miniature Bioreactor System
        3. Services
        4. Software

  • 8.   High Throughput Process Development Market, By End-user Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Biopharmaceutical Companies
        2. Contract Research Organizations
        3. Academic Research Institutes

  • 9.   High Throughput Process Development Market, By Technology Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Chromatography
         1.1. Affinity Chromatography
         1.2. Io-exchange
         1.3. Multi-modal chromatography
         1.4. Other Chromatography Technologies
        2. Ultraviolet-visible Spectroscopy
        3. Other Technologies

  • 10.   High Throughput Process Development Market, By Molecule Type Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Monoclonal Antibodies
        2. Recombinant Pro-insulin
        3. Polysaccharide vaccines
        4. Other Molecule types

  • 11.   North America High Throughput Process Development Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2025-2033

  • 12.   Latin America High Throughput Process Development Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2025-2033

  • 13.   Europe High Throughput Process Development Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2025-2033

  • 14.   Asia Pacific High Throughput Process Development Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033

  • 15.   Middle East and Africa High Throughput Process Development Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2025-2033

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Danaher
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. GE Healthcare
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Agilent Technologies
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Merck Millipore
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Thermo Fisher Scientific
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Sartorius Stedim Biotech SA
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Bio-Rad Laboratories Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. PerkinElmer Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Eppendorf SE
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. Tecan Group AG
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
         11. Repligen Corporation
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
         12. Pall Corporation
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
         13. Shimadzu Corporation
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
         14. Hamilton Company
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
         15. KBI Biopharma
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
         16. WuXi AppTec
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
         17. BioCentriq
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
         18. Premas Biotech
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients